Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

ATRC

Atricure Inc

Sep 12 • 04:00PM ET

35.07

-2.49 -6.63 %

Healthcare • Medical Instruments & Supplies • USA • NASD

Peers: BSX ABT MDT EW ISRG BIO JNJ IART LMAT ZBH

| Held by: VTI IWM VB VBK VXF IWO IHI SCHA VTWO FESM

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-0.77	Insider Own	3.63%	Shs Outstand	49.69M	Perf Week	-0.88%
Market Cap	1.74B	Forward P/E	-	EPS next Y	-0.22	Insider Trans	-0.96%	Shs Float	47.90M	Perf Month	-4.44%
Enterprise Value	1.70B	PEG	-	EPS next Q	-0.11	Inst Own	98.96%	Short Float	4.35%	Perf Quarter	8.48%
Income	-36.36M	P/S	3.49	EPS this Y	48.23%	Inst Trans	-2.71%	Short Ratio	4.12	Perf Half Y	7.05%
Sales	499.95M	P/B	3.75	EPS next Y	55.77%	ROA	-6.03%	Short Interest	2.08M	Perf YTD	14.76%
Book/sh	9.35	P/C	14.80	EPS next 5Y	-	ROE	-7.85%	52W High	43.11 -18.65%	Perf Year	30.52%
Cash/sh	2.37	P/FCF	71.96	EPS past 3/5Y	- -0.33%	ROIC	-6.75%	52W Low	25.57 37.15%	Perf 3Y	-20.42%
Dividend Est.	-	EV/EBITDA	579.06	Sales past 3/5Y	19.26% 15.05%	Gross Margin	74.10%	Volatility	5.39% 3.49%	Perf 5Y	-18.31%
Dividend TTM	-	EV/Sales	3.41	EPS Y/Y TTM	10.63%	Oper. Margin	-3.42%	ATR (14)	1.46	Perf 10Y	45.70%
Dividend Ex-Date	-	Quick Ratio	2.83	Sales Y/Y TTM	16.28%	Profit Margin	-7.27%	RSI (14)	47.29	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	3.94	EPS Q/Q	24.02%	SMA20	-3.33%	Beta	1.61	Target Price	50.00
Payout	-	Debt/Eq	0.17	Sales Q/Q	17.09%	SMA50	2.41%	Rel Volume	1.37	Prev Close	37.56
Employees	1300	LT Debt/Eq	0.16	Earnings	Jul 29 AMC	SMA200	1.97%	Avg Volume	505.76K	Price	35.07
IPO	Aug 05, 2005	Option/Short	Yes / Yes	EPS/Sales Surpr.	22.20% 4.58%	Trades		Volume	692,376	Change	-6.63%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-17-24	Resumed	JP Morgan	Overweight	$40
Apr-23-24	Upgrade	Oppenheimer	Perform → Outperform	$32
Oct-23-23	Initiated	JMP Securities	Mkt Outperform	$60
Sep-29-23	Initiated	UBS	Buy	$56
Aug-05-21	Downgrade	Oppenheimer	Outperform → Perform
Dec-18-20	Reiterated	Needham	Buy	$53 → $63
Nov-06-20	Reiterated	Needham	Buy	$63 → $53
Apr-07-20	Initiated	Oppenheimer	Outperform	$45
Feb-06-20	Initiated	BTIG Research	Buy	$42
Jan-24-20	Reiterated	Needham	Buy	$39 → $48
Aug-13-19	Downgrade	Northland Capital	Outperform → Market Perform	$30
Apr-12-19	Initiated	JP Morgan	Overweight	$37
Oct-04-18	Reiterated	Needham	Buy	$36 → $39
Aug-02-18	Reiterated	Stifel	Buy	$32 → $34
Aug-02-18	Reiterated	Needham	Buy	$32 → $36
Jun-18-18	Reiterated	Needham	Buy	$26 → $32
Apr-27-18	Reiterated	Needham	Buy	$23 → $26
Jan-16-18	Reiterated	Needham	Buy	$25 → $23
Nov-02-17	Reiterated	Needham	Buy	$26 → $25
Jul-28-17	Reiterated	Needham	Buy	$25 → $26

Show Previous Ratings

Sep-09-25 08:08AM	Do You Believe in the Upside Potential of Atricure (ATRC)? (Insider Monkey)
08:00AM	AtriCure Announces the Launch of the cryoXT Device for Post-Operative Pain Management Following Amputation (Business Wire)
Aug-20-25 08:00AM	AtriCure to Participate in the 2025 Wells Fargo Healthcare Conference (Business Wire)
Jul-30-25 03:16AM	AtriCure Inc (ATRC) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Milestones (GuruFocus.com) +10.72%
Jul-29-25 05:30PM	AtriCure (ATRC) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
05:10PM	Loading…
05:10PM	AtriCure (ATRC) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
04:08PM	AtriCure: Q2 Earnings Snapshot (Associated Press Finance)
04:01PM	AtriCure ReportsSecondQuarter2025 Financial Results; Raises Financial Outlook for 2025 (Business Wire)
Jul-28-25 08:00AM	AtriCure to Participate in the Canaccord Genuity 45th Annual Growth Conference (Business Wire) +5.46%
Jul-17-25 08:40AM	Abbott (ABT) Q2 Earnings and Revenues Top Estimates (Zacks)
Jul-15-25 08:00AM	AtriCure Completes Enrollment in LeAAPS Clinical Trial for Stroke Prevention (Business Wire)
Jul-08-25 08:00AM	AtriCure to Announce Second Quarter 2025 Financial Results (Business Wire)
Jun-30-25 09:40AM	Has Amneal Pharmaceuticals (AMRX) Outpaced Other Medical Stocks This Year? (Zacks)
Jun-12-25 09:40AM	Are Medical Stocks Lagging Astellas Pharma (ALPMY) This Year? (Zacks)
May-27-25 09:40AM	Is Astellas Pharma (ALPMY) Stock Outpacing Its Medical Peers This Year? (Zacks)
08:00AM	Loading…
May-23-25 08:00AM	AtriCure to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference (Business Wire)
May-15-25 09:55AM	Does AtriCure (ATRC) Have the Potential to Rally 54.7% as Wall Street Analysts Expect? (Zacks)
Apr-30-25 08:07AM	Q1 2025 AtriCure Inc Earnings Call (Thomson Reuters StreetEvents) -13.68%
03:15AM	AtriCure Inc (ATRC) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... (GuruFocus.com)
Apr-29-25 09:34PM	AtriCure, Inc. (ATRC) Q1 2025 Earnings Call Transcript (Seeking Alpha)
05:30PM	AtriCure (ATRC) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
05:10PM	AtriCure (ATRC) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:07PM	AtriCure: Q1 Earnings Snapshot (Associated Press Finance)
04:01PM	AtriCure Reports First Quarter 2025 Financial Results (Business Wire)
Apr-10-25 11:37AM	LeMaitre (LMAT) Soars 7.7%: Is Further Upside Left in the Stock? (Zacks)
08:00AM	AtriCure Announces First Use of the AtriClip PRO-Mini Device (Business Wire)
Apr-09-25 08:10AM	Neogen (NEOG) Lags Q3 Earnings and Revenue Estimates (Zacks) +8.13%
Apr-08-25 12:18PM	AtriCure Drops 25%: Bargain Or Caution Sign? (Seeking Alpha)
08:00AM	AtriCure to Announce First Quarter 2025 Financial Results (Business Wire)
Mar-12-25 08:00AM	AtriCure to Host Analyst & Investor Day on March 26, 2025 (Business Wire)
12:00PM	Loading…
Feb-13-25 12:00PM	AtriCure (ATRC) Upgraded to Buy: Here's What You Should Know (Zacks) -6.54%
10:29AM	Q4 2024 AtriCure Inc Earnings Call (Thomson Reuters StreetEvents)
02:16AM	AtriCure Inc (ATRC) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... (GuruFocus.com)
Feb-12-25 05:30PM	Here's What Key Metrics Tell Us About AtriCure (ATRC) Q4 Earnings (Zacks)
05:15PM	AtriCure (ATRC) Reports Q4 Loss, Lags Revenue Estimates (Zacks)
04:38PM	AtriCure: Q4 Earnings Snapshot (Associated Press Finance)
04:01PM	AtriCure Reports Fourth Quarter 2024 and Full Year 2024 Financial Results (Business Wire)
Feb-11-25 09:15AM	Exploring Analyst Estimates for AtriCure (ATRC) Q4 Earnings, Beyond Revenue and EPS (Zacks)
Feb-05-25 10:00AM	Will AtriCure (ATRC) Report Negative Earnings Next Week? What You Should Know (Zacks)
Jan-23-25 06:26PM	Why AtriCure, Inc. (ATRC) Is Skyrocketing Now (Insider Monkey)
Jan-22-25 08:00AM	AtriCure to Announce Fourth Quarter and Full Year 2024 Financial Results (Business Wire)
Jan-13-25 08:00AM	AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2024, Provides Financial Outlook for 2025, and Announces Upcoming Analyst and Investor Day (Business Wire) +9.49%
Dec-23-24 08:00AM	AtriCure to Participate in the 43rd Annual J.P. Morgan Healthcare Conference (Business Wire)
Nov-20-24 08:00AM	AtriCure to Participate in the Piper Sandler 36th Annual Healthcare Conference (Business Wire)
Nov-07-24 08:00AM	AtriCure to Participate in the Stifel 2024 Healthcare Conference (Business Wire)
Oct-30-24 10:19AM	Q3 2024 AtriCure Inc Earnings Call (Thomson Reuters StreetEvents) +18.35%
03:12AM	AtriCure Inc (ATRC) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amidst Market Challenges (GuruFocus.com)
Oct-29-24 07:00PM	AtriCure (ATRC) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
05:10PM	AtriCure (ATRC) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
04:07PM	AtriCure: Q3 Earnings Snapshot (Associated Press Finance)
04:01PM	AtriCure Reports Third Quarter 2024 Financial Results (Business Wire)
Oct-28-24 08:00AM	AtriCure to Participate in the UBS Global Healthcare Conference (Business Wire)
Oct-15-24 08:00AM	AtriCure Announces Launch of cryoSPHERE MAX Probe for Post-Operative Pain Management (Business Wire)
Oct-08-24 08:00AM	AtriCure to Announce Third Quarter 2024 Financial Results (Business Wire)
Oct-01-24 08:00AM	AtriCure Receives CE-Mark for the EnCompass Clamp (Business Wire)
Sep-18-24 10:43AM	Heres Why TimesSquare Capital U.S. Small Cap Growth Strategy Decided to Sell AtriCure (ATRC) (Insider Monkey)
Aug-28-24 06:32AM	AtriClip FLEX-Mini device treatment begins with first patient (Medical Device Network)
Aug-27-24 08:00AM	AtriCure Announces that the First Patient has been Treated with the Revolutionary AtriClip FLEX-Mini Device (Business Wire)
Aug-23-24 12:07PM	AtriCure's (ATRC) AtriClip Receives Expanded CE-Mark Indication (Zacks)
Aug-22-24 08:00AM	AtriCure Receives Expanded CE-Mark Indication for AtriClip Devices for the Reduction of Stroke in Patients with Atrial Fibrillation (Business Wire)
Jul-30-24 05:30PM	AtriCure (ATRC) Reports Q2 Earnings: What Key Metrics Have to Say (Zacks)
05:10PM	AtriCure (ATRC) Reports Q2 Loss, Lags Revenue Estimates (Zacks)
04:09PM	AtriCure: Q2 Earnings Snapshot (Associated Press Finance)
04:01PM	AtriCure Reports Second Quarter 2024 Financial Results (Business Wire)
Jul-29-24 08:00AM	AtriCure to Participate in the Canaccord Genuity 44th Annual Global Growth Conference (Business Wire)
Jul-24-24 10:14AM	AtriCure (ATRC) Gains China Approval for AtriClip LAA System (Zacks)
Jul-23-24 08:00AM	AtriCure Receives Regulatory Approval to Sell AtriClip Devices in China (Business Wire)
Jul-09-24 08:00AM	AtriCure to Announce Second Quarter 2024 Financial Results (Business Wire)
Jun-28-24 06:50AM	Have 20 Bucks? 7 Low-Priced Stocks That Could Double by 2025 (InvestorPlace)
Jun-21-24 01:44AM	AtriCure (ATRC) Stock Slipped on Competition Threat (Insider Monkey)
May-31-24 07:00PM	Insider Buying: Chief Technical Officer Salvatore Privitera Acquires Shares of AtriCure Inc (ATRC) (GuruFocus.com)
May-15-24 08:00AM	AtriCure to Participate in the 2024 Leerink Partners Healthcare Crossroads Conference (Business Wire)
May-02-24 03:18PM	AtriCure, Inc. (NASDAQ:ATRC) Q1 2024 Earnings Call Transcript (Insider Monkey) -10.26%
08:36AM	Needham Lowers AtriCure's PT to $40 From $46 Due to Peer Multiple Contraction, Keeps Buy Rating (MT Newswires)
03:49AM	AtriCure Inc (ATRC) Q1 2024 Earnings Call Transcript Highlights: Strong Revenue Growth and ... (GuruFocus.com)
May-01-24 08:57PM	ATRC Stock Earnings: AtriCure Misses EPS, Beats Revenue for Q1 2024 (InvestorPlace)
08:00PM	Compared to Estimates, AtriCure (ATRC) Q1 Earnings: A Look at Key Metrics (Zacks)
05:55PM	AtriCure Inc (ATRC) Surpasses Revenue Estimates in Q1 2024 Despite Wider Losses (GuruFocus.com)
05:30PM	AtriCure (ATRC) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:34PM	AtriCure: Q1 Earnings Snapshot (Associated Press Finance)
04:01PM	AtriCure Reports First Quarter 2024 Financial Results (Business Wire)
Apr-30-24 08:00AM	AtriCure to Participate in the 2024 Bank of America Securities Healthcare Conference (Business Wire)
Apr-23-24 07:07AM	--Oppenheimer Upgrades AtriCure to Outperform, Price Target at $32 (MT Newswires)
Apr-19-24 09:45AM	AtriCure's (ATRC) cryoSPHERE+ Probe to Aid in Pain Management (Zacks)
Apr-18-24 08:00AM	AtriCure Announces Launch of the cryoSPHERE+ Probe for Post-Operative Pain Management (Business Wire)
Apr-10-24 08:00AM	AtriCure to Announce First Quarter 2024 Financial Results (Business Wire) -6.19%
Mar-26-24 08:00AM	AtriCure to Participate in the 23rd Annual Needham Virtual Healthcare Conference (Business Wire)
Mar-22-24 06:40AM	AtriCure (ATRC) Declined due to Concerns Over Anti-Obesity Drug (Insider Monkey)
Mar-07-24 09:01AM	Chief Legal Officer Karl Dahlquist Sells 8,231 Shares of AtriCure Inc (ATRC) (GuruFocus.com)
Feb-28-24 12:47AM	AtriCure (ATRC) Fell on Competitor Action (Insider Monkey)
Feb-16-24 11:30AM	AtriCure, Inc. (NASDAQ:ATRC) Q4 2023 Earnings Call Transcript (Insider Monkey)
09:24AM	Q4 2023 AtriCure Inc Earnings Call (Thomson Reuters StreetEvents)
Feb-15-24 07:00PM	Here's What Key Metrics Tell Us About AtriCure (ATRC) Q4 Earnings (Zacks) +5.13%
05:10PM	AtriCure (ATRC) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
04:44PM	AtriCure Inc (ATRC) Reports Strong Revenue Growth in Q4 and Full Year 2023 (GuruFocus.com)
04:15PM	AtriCure: Q4 Earnings Snapshot (Associated Press Finance)
04:01PM	AtriCure Reports Fourth Quarter 2023 and Full Year 2023 Financial Results (Business Wire)
Feb-12-24 09:16AM	Seeking Clues to AtriCure (ATRC) Q4 Earnings? A Peek Into Wall Street Projections for Key Metrics (Zacks)
Jan-25-24 08:00AM	AtriCure to Announce Fourth Quarter and Full Year 2023 Financial Results and Participate in 2024 BTIG Medical Technology Conference (Business Wire)
Jan-08-24 08:00AM	AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2023, Provides Financial Outlook for 2024 (Business Wire) +6.06%

AtriCure, Inc. engages in the development, manufacture, and sale of surgical ablation of cardiac tissue, and systems for the exclusion of the left atrial appendage. Its products include radio frequency (RF) ablation pacing and sensing, cryo, left atrial appendage management, soft tissue dissection, estech surgical instrumentation, and cart configuration. It operates through the following geographical segments: United States, Europe, Asia, and Other International. The company was founded in 1994 and is headquartered in Mason, OH.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Noznesky Justin J	Officer	Sep 12 '25	Proposed Sale	36.30	3,000	108,891		Sep 12 02:17 PM
WEHRWEIN SVEN	Director	Aug 22 '25	Option Exercise	19.95	5,000	99,750	39,374	Aug 26 08:27 AM
WEHRWEIN SVEN	Director	Aug 22 '25	Sale	37.00	5,000	185,000	34,374	Aug 26 08:27 AM
SVEN WEHRWEIN	Director	Aug 22 '25	Proposed Sale	37.00	5,000	185,000		Aug 22 04:01 PM
WEHRWEIN SVEN	Director	Aug 19 '25	Option Exercise	19.95	5,000	99,750	39,374	Aug 21 09:04 AM
WEHRWEIN SVEN	Director	Aug 19 '25	Sale	36.00	5,000	180,000	34,374	Aug 21 09:04 AM
SVEN WEHRWEIN	Director	Aug 19 '25	Proposed Sale	36.00	5,000	180,000		Aug 19 04:12 PM
GROVES REGINA E	Director	Aug 06 '25	Sale	36.82	2,452	90,283	33,715	Aug 08 09:12 AM
Doraiswamy Vinayak	Chief Scientific Officer	Aug 05 '25	Sale	36.58	2,500	91,450	71,872	Aug 07 08:45 AM
GROVES REGINA E	Director	Aug 06 '25	Proposed Sale	36.83	2,452	90,307		Aug 06 10:38 AM
VINAYAK DORAISWAMY	Officer	Aug 05 '25	Proposed Sale	36.58	2,500	91,442		Aug 05 04:08 PM
Doraiswamy Vinayak	Chief Scientific Officer	May 28 '25	Sale	33.44	2,500	83,600	73,550	May 30 04:21 PM
VINAYAK DORAISWAMY	Officer	May 28 '25	Proposed Sale	33.44	2,500	83,600		May 28 04:02 PM
WHITE ROBERT S.	Director	May 05 '25	Option Exercise	22.62	10,000	226,200	106,773	May 07 08:25 AM
Prange Karen	Director	Mar 05 '25	Sale	38.12	6,100	232,532	17,828	Mar 07 08:21 AM
Prange Karen	Director	Mar 05 '25	Proposed Sale	38.04	6,100	232,044		Mar 05 10:02 AM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

ATRC

Atricure Inc

Upgrade your FINVIZ experience